journal article·2013-11

The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation

Gajadhar Bhakta, Zophia X.H. Lim, Bina Rai, Tingxuan Lin, James H. Hui, Glenn D. Prestwich, Andre J. van Wijnen, Victor Nurcombe, Simon M. Cool

Acta Biomaterialia· Volume 9· Issue 11
Publisher page

Abstract

Bone morphogenetic protein-2 (BMP-2) is known to enhance fracture healing when delivered via a bovine collagen sponge. However, collagen rapidly releases BMP-2 with a high burst phase that is followed by a low sustained phase. As a result, supra-physiological doses of BMP-2 are often required to successfully treat bone defects. High BMP-2 dosing can introduce serious side effects that include edema, bone overgrowth, cyst-like bone formation and significant inflammation. As the release behavior of BMP-2 carriers significantly affects the efficacy of fracture healing, we sought to compare the influence of two BMP-2 delivery matrices with contrasting release profiles on BMP-2 bioactivity and ectopic bone formation. We compared a thiol-modified hyaluronan (Glycosil™) hydrogel that exhibits a low burst followed by a sustained release of BMP-2 to a collagen sponge for the delivery of three different doses of BMP-2, the bioactivities of released BMP-2 and ectopic bone formation. Analysis of bone formation by micro-computed tomography revealed that low burst followed by sustained release of BMP-2 from a hyaluronan hydrogel induced up to 456% more bone compared to a BMP-2 dose-matched collagen sponge that has a high burst and sustained release. This study demonstrates that BMP-2 released with a low burst followed by a sustained release of BMP-2 is more desirable for bone formation. This highlights the therapeutic potential of hydrogels, particularly hyaluronan-based, for the delivery of BMP-2 for the treatment of bone defects and may help abrogate the adverse clinical effects associated with high dose growth factor use.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Bone Tissue Engineering Materials · TGF-β signaling in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft)10.1007/s00264-007-0418-6 ↗
2. Bone morphogenetic proteins and spinal fusion10.3171/foc.2002.13.6.4 ↗
3. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2)10.1016/j.spinee.2007.06.014 ↗
4. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts10.1016/S8756-3282(00)00358-6 ↗
5. Collagen sponges for bone regeneration with rhBMP-210.1016/j.addr.2003.08.010 ↗
6. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am. 2001; 83-A Suppl 1:S128–35.10.2106/00004623-200100002-00007 ↗
7. Bone morphogenetic protein delivery systems10.1097/00007632-200208151-00005 ↗
8. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing10.1359/jbmr.2002.17.3.513 ↗
9. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies10.2106/JBJS.E.00499 ↗
10. Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite10.1089/ten.tea.2007.0376 ↗
11. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-210.1002/jbm.a.31782 ↗
12. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release10.1089/ten.tea.2010.0446 ↗
13. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways10.1083/jcb.200806049 ↗
14. Bone morphogenetic proteins in human bone regeneration10.1530/eje.0.1420009 ↗
15. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures10.1002/jor.20182 ↗
16. Delivering on the promise of bone morphogenetic proteins10.1016/S0167-7799(01)01665-1 ↗
17. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering10.1007/s10529-009-0100-8 ↗
18. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery10.1007/s10529-009-0099-x ↗
19. Hyaluronan: its nature, distribution, functions and turnover10.1046/j.1365-2796.1997.00170.x ↗
20. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity10.1016/j.joca.2004.11.010 ↗
21. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor10.1016/j.biomaterials.2005.03.012 ↗
22. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels10.1016/j.biomaterials.2010.02.043 ↗
23. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats10.1016/j.actbio.2011.04.021 ↗
24. Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation10.1016/j.jconrel.2011.02.003 ↗
25. Layer-by-layer films as a biomimetic reservoir for rhBMP-2 delivery: controlled differentiation of myoblasts to osteoblasts10.1002/smll.200800804 ↗
26. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-210.1016/j.biomaterials.2012.05.030 ↗
27. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage10.1083/jcb.127.6.1755 ↗
28. 3D imaging of tissue integration with porous biomaterials10.1016/j.biomaterials.2008.06.018 ↗
29. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011;23:H41–56.10.1002/adma.201003963 ↗
30. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release. 2011; 155:193–99.10.1016/j.jconrel.2011.04.007 ↗
31. Engineering a clinically-useful matrix for cell therapy10.4161/org.6152 ↗
32. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery10.1021/ar7000827 ↗
33. The translational imperative: making cell therapy simple and effective10.1016/j.actbio.2012.06.043 ↗
34. Disulfide cross-linked hyaluronan hydrogels10.1021/bm025603c ↗
35. In situ crosslinkable hyaluronan hydrogels for tissue engineering10.1016/j.biomaterials.2003.08.014 ↗
36. Biocompatibility and stability of disulfide-crosslinked hyaluronan films10.1016/j.biomaterials.2005.01.003 ↗
37. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel10.1002/jbm.a.20002 ↗
38. Localized delivery of growth factors for bone repair10.1016/j.ejpb.2004.03.004 ↗
39. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration10.1016/j.cytogfr.2005.05.001 ↗
40. Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix10.1002/jor.20148 ↗
41. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro10.1002/jbm.10011 ↗
42. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine10.1016/j.jconrel.2011.04.007 ↗
43. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery10.1016/j.bbrc.2008.02.099 ↗